AGMT
  • About us
    • About us
    • Executive board
    • Partner
    • Team
    • Contact
  • Trials
    • Hodgkin Lymphoma
      • HD 21
      • AERN
      • BRESELIBET
    • Non-Hodgkin Lymphoma
      • DSHNHL_NIVEAU
      • ORACLE
      • Pola-R-ICE
    • Multiple Myeloma
      • MM-4
    • Pancreatic Cancer
      • DIsCOvER
    • COVID-19
      • INSERM_DisCoVeRy
  • Registries
    • AIHA Registry
    • aMYELOIDr
    • ARIADNE NIS
    • CLL-Registry
    • COVID-19 Registry
    • LungCA Registry
    • MBC Registry
    • NGS Registry
    • PTCL Registry
  • Events
    • Breast Cancer Talk – 2020
  • Publications
  • News
    • News Overview
    • News Archive
  • Contact
  • AAA
  • Login
  • en
    Languages
    • en English
    • de Deutsch
Breast Cancer Talk 2022

Salzburg Breast Cancer Talk

In order of appearanceThe Faculty

Prof. Richard Greil MD
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Rebecca Dent MD FRCP (Canada)
Chair, Divison of Medical Oncology & Senior Consultant, National Cancer Center Singapore
Professor, Duke-NUS Medical School, Singapore
Dr. Denise Wolf PhD
Senior Bioinformatics Scientist, Department of Laboratory Medicine, University of California, San Francisco, CA, USA
Dr. Amrita Basu PhD
Assistant Professor, Department of Surgery, University of California, San Francisco, CA, USA
Prof. Dr. Fritz Aberger
Molecular Cancer and Stem Cell Research, Lab Department of Molecular Biology, University of Salzburg, Cancer Cluster Salzburg (CCS), Salzburg, Austria
Assoc. Prof. Gabriel Rinnerthaler MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Luca Gianni MD
Chair, Breast Cancer Research Committee, Michelangelo Foundation, Milano, Italy
Dr. Roberto Salgado
Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia
Prof. Pedro Romero MD
Deputy scientific managing director of the Lausanne Branch of the Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Switzerland
Prof. Alexander Egle MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Dr. Iosifina Foskolou
Department of Haematopoiesis, Sanquin, Amsterdam, NL and
Department of Physiology, Development and Neuroscience, Cambridge University, UK
Prof. Dr. Barbara Seliger
Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Prof. Laurence Zitvogel MD PhD
Gustave Roussy Comprehensive Cancer Institute, Villejuif, France
Université Paris Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France, INSERM U1015, Villejuif, France
Berna Özdemir MD PhD
Department of Medical Oncology, Bern University Hospital and University of Bern, Switzerland
Priv.-Doz. Simon P. Gampenrieder MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Giuseppe Curigliano MD PhD
Professor of Medical Oncology, University of Milano, Head of Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy
Prof. Dr. Niels Schaft PhD

Research group leader of the RNA-based Immunotherapy group, Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

finalProgramme

Friday, 21. October 2022

12:30 – 13:30 Welcome & Business Lunch


13:30 – 13:35 Introduction
Richard Greil, Salzburg


13:35 – 15:30 Clinical and Translational research
Chair: Richard Greil, Denise M. Wolf
Current evidence of immunotherapy in early breast cancer
Rebecca Dent (Singapore)
Predictive biomarkers for immunotherapy – findings from the I-SPY 2 trial
Denise M. Wolf (California)
Predictive factors for immune-related side effects
Amrita Basu (California)
Panel-Discussion
All speakers
Moderator: Richard Greil (Salzburg)


15:30 – 16:00 Coffee Break


16:00 – 18:30 Innate and adaptive Immune system
Fritz Aberger, Gabriel Rinnerthaler
Single-Cell spatial immune cell composition – findings from the NeoTRIPaPDL1 trial
Luca Gianni (Milano)
PD-L1 vs. TILs: analytic and diagnostic issues
Roberto Salgado (Antwerp)
Harnessing metabolic pathways to enhance antitumor immunity and immunotherapy
Pedro Romero (Lausanne)
Panel-Discussion
All speakers
Moderator: Richard Greil (Salzburg)


Saturday, 22. October 2022

08:30 – 11:00 Metabolism & Immunogenicity
Chair: Pedro Romero,  Alexander Egle
Hypoxia-inducible metabolites shape T cell fate
Iosifina Foskolou (Cambridge)
Immune escape in breast cancer and its therapeutic relevance
Barbara Seliger (Halle)
Influence on immunogenicity by the microbioma
Laurence Zitvogel (Paris)
Influence on immunogenicity by sex hormones
Berna C. Özdemir (Lausanne)
Panel-Discussion (focusing on immunogenicity)
All speakers
Moderator: Richard Greil (Salzburg)


11:00 – 11:30 Coffee break


11:30 – 13:00 New treatment strategies
Chair: Simon Gampenrieder,  Niels Schaft
Immunotherapy strategies beyond PD1/PD-L1 inhibition
Giuseppe Curigliano (Milano)
CAR T-Cells in breast cancer
Niels Schaft (Erlangen)
Panel discussion
All speakers
Moderator: Richard Greil (Salzburg)

Closing Remarks
Richard Greil (Salzburg)


13:00 – 14:00 Business Lunch & Farewell


Registration

The registration form is now available, we look forward to your submission. We would like to point out that this conference is not open to the public. After your registration your entries will be checked by us, followed by information about your requested participation.

Accreditation by ÖÄK

4th SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology has been accredited by the Diploma Continuing Education Program of the Austrian Medical Association (ÖÄK) for a maximum of 11 DFP points.

Venue

We have a new location for 2022:

Hotel Gersbergalm
Gersberg 37
5020 Salzburg

The hotel can be reached by car (sufficient parking available), by bus (line 151) or by cab (still city area).

Organisation

Prof. Dr. Richard Greil

Dr. Simon P. Gampenrieder
Dr. Gabriel Rinnerthaler

AGMT gemeinnützige GmbH

Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (SCRI-LIMCR)

Center for Clinical Cancer and Immunology Trials (SCRI-CCCIT)

in Kooperation mit
Cancer Cluster Salzburg | www.cancercluster-salzburg.at

Photos

BreastCancerTalk 2022

f.l.t.r. R. Salgado (blue shirt), N. Schaft (behind), I. Foskolou (2. row), R. Greil, P. Romero, S. Gampenrieder, D. Wolf, G. Rinnerthaler (behind), A. Basu

BreastCancerTalk 2022

Introduction by Prof. Greil

BreastCancerTalk 2022

Online Lecture of Prof. Dent (Singapore)

BreastCancerTalk 2022

Lecture of Dr. Wolf (California)

BreastCancerTalk 2022

Priv-Doz. Dr. Gampenrieder as Co-Initiator of BCT

BreastCancerTalk 2022

Lecture of Dr. Wolf (California)

BreastCancerTalk 2022

Online Lecture of Prof. Dent (Singapore)

BreastCancerTalk 2022

Prof. Dr. Niels Schaft, PhD

Photos: Franz Neumayr

Video

News

11Oct
Results from AGMT_MM-1 published

In September, two publications on the AGMT_MM-1 study were published....

16Nov
3rd SALZBURG BREAST CANCER TALK

01.- 02.03.2019  Salzburg   —   MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY...

10Mar
2nd SALZBURG BREAST CANCER TALK

02.- 03.03.2018  Salzburg   —   MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY...

11Jan
SALZBURG BREAST CANCER TALK

10.- 11.02.2017  Salzburg   —   MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY...

Breast Cancer Talk
  • Events
    • Breast Cancer Talk – 2022
    • Program
    • Venue
    • Organisation
  • Breast Cancer Talk – 2018
  • Breast Cancer Talk – 2019
Arbeitsgemeinschaft medikamentöse Tumortherapie gemeinnützige GmbH
Firmensitz und Rechnungsadresse: Gentzgasse 60/21, 1180 Wien
Zweigstelle & Zustelladresse: Wolfsgartenweg 31, 5020 Salzburg
Firmenbuchnummer: FN 289548 g
UID-Nummer: ATU63467108
+43 662 640 44 12
+ 43 664 142 25 04
+43 662 640 44 14
office@agmt.at
Copyright © AGMT gemeinnützige GmbH
  • Site notice
  • Data protection declaration
  • LinkedIn AGMT